Bio Invest News
-
Exploring Synergies: How Biotech Companies and Startups Can Drive Breakthrough Therapies
Bio Invest | Company results | By Hithaishi C Bhaskar | 0 Comment | 28 Jul, 2023
Leading global biotechnology company Amgen and NSG BioLabs, Singapore’s largest provider of biotech co-working lab...Read more
-
ASEAN Businesses to get funding for mediating IP or technology disputes
Bio Invest | Regulatory | 0 Comment | 03 Jul, 2023
Businesses in the Association of Southeast Asian Nations (ASEAN) can now benefit from subsidised mediation ...Read more
-
SomaLogic unveils first-ever proteomics grant program to APAC life sciences researchers
Bio Invest | News | 0 Comment | 08 May, 2023
SomaLogic, Inc., a global leader in proteomics technology, has announced tis first grant in the APAC region by spon...Read more
-
Is Asian life sciences industry losing confidence in US after SVB failure?
Bio Invest | News | 0 Comment | 14 Mar, 2023
The sudden collapse of a major bank- Silicon Valley Bank (SVB)- in the United States (US) might have unexpected conseque...Read more
-
Bio Invest | News | 0 Comment | 10 Mar, 2023
On March 10th, The Wharton School of the University of Pennsylvania kicked off the 55th Wharton Global Forum i...Read more
-
Tanaka makes equity contribution for establishing medical venture ecosystem in Japan
Bio Invest | News | 0 Comment | 20 Dec, 2022
Tokyo based TANAKA Kikinzoku Kogyo K.K. has made an equity contribution to the medical venture capital fund 'Diamond Med...Read more
-
Bio Invest | Opinion | By Hithaishi C Bhaskar | 0 Comment | 12 Oct, 2022
Meaningful partnerships and collaborations are indispensable to narrow the disparities among stakeholders in a multiface...Read more
-
ArchiMed invests in PlasmidFactory, a German gene and cell therapy specialist
Bio Invest | News | 0 Comment | 28 Sep, 2022
Trans-Atlantic private equity healthcare specialist ArchiMed has invested in Bielefeld, Germany-based PlasmidFactory. Fo...Read more
-
Astrea Bioseparations makes critical infrastructure investments in Cambridge, UK and Singapore
Bio Invest | News | 0 Comment | 17 Sep, 2021
The investments include an expansion of the company’s research and development facility in Cambridge, United Kingd...Read more
-
The UK government launches 'UK Life Sciences Vision'
Bio Invest | News | 0 Comment | 19 Jul, 2021
The United Kingdom (UK) government aims to accelerate the delivery of novel innovations at patient care through the ...Read more
-
Adlai Nortye raises $100 M (Series D) to accelerate clinical and drug development programs
Bio Invest | News | 0 Comment | 15 Jul, 2021
Adlai Nortye Ltd., a global biopharmaceutical company focused on developing innovative oncology drugs, has complete...Read more
-
TVM Capital Healthcare strengthens its leadership in Southeast Asia regions
Bio Invest | News | 0 Comment | 05 Jul, 2021
TVM Capital Healthcare, a global specialist healthcare private equity firm operating in emerging markets, announced that...Read more
-
Hong Kong's biopharma CDMO extends business development services to investors
Bio Invest | News | 0 Comment | 03 Jun, 2021
Peking University Biologics (PKU BIO) and Norwich Investment Limited (Norwich) announced a Strategic Cooperati...Read more
-
IFC and Mitsui to invest US$60M in Singapore-based MiCare Health Technologies
Bio Invest | News | 0 Comment | 27 May, 2021
MiCare HealthTEC Holdings Pte Ltd, a subsidiary of Zuellig Pharma and a leading medical claims ...Read more
-
BIO KOREA 2021 preparing to unravel Biohealth market
Bio Invest | News | 0 Comment | 21 Apr, 2021
The 16th edition of BIO KOREA, the reference B2B event for global biotech and health industry professionals interes...Read more
-
China's AffaMed Therapeutics completes US$170M Series B financing
Bio Invest | News | 0 Comment | 30 Mar, 2021
Shanghai's AffaMed Therapeutics (“AffaMed”), a global clinical-stage biopharmaceutical company dedicated to ...Read more
-
Vietnam boosts innovation and startup ecosystem
Bio Invest | News | 0 Comment | 11 Jan, 2021
Vietnam has launched the construction of National Innovation Centre (NIC), worth 740 billion VND ($32 million), spr...Read more
-
VISEN raises $150M in Series B to accelerate innovative endocrinology therapies in Greater China
Bio Invest | News | 0 Comment | 11 Jan, 2021
VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs that addre...Read more
